Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Not yet recruiting 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 6Biliary Tract Neoplasms 5Rectal Neoplasms 3Colonic Neoplasms 3Gastrointestinal Stromal Tumors 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Piebaldism 1Pancreatic Neoplasms 1Locally Advanced Rectal Carcinoma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 95Cisplatin 72Capecitabine 39Oxaliplatin 38durvalumab 29Fluorouracil 27pembrolizumab 26Leucovorin 23S 1 (combination) 19Nivolumab 14Irinotecan 14lenvatinib 13Bevacizumab 13tremelimumab 10130-nm albumin-bound paclitaxel 9apatinib 8Trastuzumab 7Injections 7Immune Checkpoint Inhibitors 7Docetaxel 7Albumin-Bound Paclitaxel 7Paclitaxel 6Drug Therapy 6titanium silicide 5surufatinib 5irinotecan sucrosofate 5gemcitabine-oxaliplatin regimen 5envafolimab 5camrelizumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × envafolimab × Gastrointestinal × Clear all
NCT07599995 2026-05-20

GENE

Sir Run Run Shaw Hospital

Phase 2 Not yet recruiting
34 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT04910386 2026-03-25

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

3D Medicines

Phase 2 Not yet recruiting
126 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT07003815 2025-06-04

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

Tongji Hospital

Phase 2 Not yet recruiting
62 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT03478488 2025-05-29

KN035-BTC

3D Medicines

Phase 3 Active not recruiting
480 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT05417230 2022-06-14

RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2

Jiangsu Cancer Institute & Hospital

Phase 2 Unknown
29 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡